(Q48884068)

16 February 2018

title

Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time (English)

1 reference

16 February 2018

author

Hidehiko Okazawa

5

1 reference

16 February 2018

author name string

Y Onishi

1

1 reference

16 February 2018

Y Yonekura

2

1 reference

16 February 2018

F Tanaka

3

1 reference

16 February 2018

S Nishizawa

4

1 reference

16 February 2018

K Ishizu

6

1 reference

16 February 2018

T Fujita

7

1 reference

16 February 2018

J Konishi

8

1 reference

16 February 2018

T Mukai

9

1 reference

16 February 2018

publication date

1 November 1996

1 reference

16 February 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

16 February 2018

volume

23

1 reference

16 February 2018

issue

11

1 reference

16 February 2018

page(s)

1491-1497

1 reference

16 February 2018

Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil

cites work

1 reference

12 December 2020

Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET compari son

1 reference

12 December 2020

[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases]

1 reference

12 December 2020

123-I-iomazenil-SPECT in patients with focal epilepsies--a comparative study with 99mTc-HMPAO-SPECT, CT and MR

1 reference

12 December 2020

Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging

1 reference

12 December 2020

[Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP]

1 reference

12 December 2020

Registration of three-dimensional MR and PET images of the human brain without markers

1 reference

12 December 2020

123I-iomazenil: a quantitative study of the central benzodiazepine receptor distribution

1 reference

12 December 2020

SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments

1 reference

12 December 2020

Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans

1 reference

12 December 2020

Imaging benzodiazepine receptors in the human brain by single photon emission computed tomography (SPECT)

1 reference

12 December 2020

Evaluation of focal epilepsy: a SPECT scanning comparison of 123-I-iomazenil versus HM-PAO

1 reference

12 December 2020

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

12 December 2020

In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci

1 reference

12 December 2020

[Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT]

1 reference

12 December 2020

Identification of the side of epileptic focus with 123I-Iomazenil SPECT. A comparison with 18FDG-PET and ictal EEG findings in patients with medically intractable complex partial seizures

1 reference

12 December 2020

Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report

1 reference

12 December 2020

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography

1 reference

12 December 2020

Central benzodiazepine receptor distribution after subcortical hemorrhage evaluated by means of [123I]iomazenil and SPECT

1 reference

12 December 2020

Benzodiazepine receptors and cerebral blood flow in partial epilepsy

1 reference

12 December 2020

[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders]

1 reference

12 December 2020

Evaluation of a multicentre study with Iomazenil - a benzodiazepine receptor ligand

1 reference

12 December 2020

[Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT]

1 reference

12 December 2020

Evaluation of cerebral infarction with iodine 123-iomazenil SPECT

1 reference

12 December 2020

In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors

1 reference

12 December 2020

Noninvasive quantification of iodine-123-iomazenil SPECT.

1 reference

12 December 2020

Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil

1 reference

12 December 2020

[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy]

1 reference

12 December 2020

SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters

1 reference

12 December 2020

Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine

1 reference

12 December 2020

SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms

1 reference

12 December 2020

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01254474

1 reference

16 February 2018

1 reference

16 February 2018